Catalent completes $5.5m expansion to help serve large-scale clinical studies

By Melissa Fassbender contact

- Last updated on GMT

(Image: Catalent Pharma Solutions)
(Image: Catalent Pharma Solutions)
The delivery technologies and development solutions provider Catalent Pharma Solutions today announced it has completed a $5.5m expansion program at its 200,000+ square foot Philadelphia, PA.

One of the largest sites in Catalent’s global clinical supply network, the expanded facility provides additional clinical packaging and storage capacity.

According to the company, the investment has resulted in a 40% increase in pallet space for both refrigerated and ambient clinical storage. It has also added extra cold chain packaging areas and a new clinical label control area. Additionally, the facility features a new environmental monitoring and building management system.

“Studies have become more global and complex, so the mix of services required to supply them has grown too,"​ said Bernie Clark, vice president of marketing and strategy for clinical supply services at Catalent.

Additionally, Clark said the company is experiencing strong growth from both long-term and new partners.

"As sponsors often don’t have all the resources themselves, they are reassessing their outsourcing strategy,"​ he told us.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Flow Cytometry Services

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us

Products

View more

Webinars